AN2 Therapeutics, Inc. Common Stock —— 季度财务报表 (NASDAQ:ANTX) | MetaTrader

展开完整图表

Financials

概览声明统计股息

每季度年度

Market Capitalization 167.84 M
Employee 21
Founded 2017
CEO N/A
Website www.an2therapeutics.com
Headquarter Delaware, United States
FIGI BBG00QYLYBK4
Industry 生物技术

总收入

净利润

每股基本收益（基本 EPS）

总债务

自由现金流

现金及现金等价物

Related tickers

	#	姓名	价格	24小时 %	7天 %	一个月 %	一年 %	市值	最近7天
	3744	ALEC Alector, Inc. - Common Stock	1.50 USD	+7.91%	-18.03%	+2.04%	-5.66%	166.54 M USD
	3745	CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock	9.03 USD	0.00%	-5.45%	+8.80%	-45.60%	167.31 M USD
	3752	ABOS Acumen Pharmaceuticals, Inc. - Common Stock	2.21 USD	-12.65%	-19.05%	-5.56%	+66.17%	159.62 M USD
	3753	ORMP Oramed Pharmaceuticals Inc. - Common Stock	4.06 USD	+1.50%	-5.36%	+6.28%	+92.42%	166.16 M USD